Simply Wall St.156d agoneutral
How The Ocugen (OCGN) Investment Story Is Evolving Without New Analyst GuidanceNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.184d agoneutral
Ocugen (OCGN) Is Down 16.8% After $115M Convertible Notes Deal And Wider Q1 Losses Has The Bull Case Changed?Insider Monkey191d agoneutral
Ocugen (OCGN) Completes Enrollment for Phase 2/3 Pivotal Trial of OCU410ST Gene TherapySimply Wall St.196d agoneutral
How The Ocugen (OCGN) Story Is Shifting With Gene Therapy Milestones And Valuation DebateSimply Wall St.200d agoneutral
Ocugen (OCGN) Valuation Check After Encouraging Phase 2 ArMaDa Results For OCU410Simply Wall St.201d agoneutral
OCU410’s Phase 2 Gene‑Agnostic Results in Dry AMD Might Change The Case For Investing In Ocugen (OCGN)